A randomized controlled double-blinded clinical trial

Not Applicable

Recruiting

• Conditions: Condition 1: Scars. Condition 2: Burn of head, face, and neck sequela. Condition 3: Burn of trunk sequela. Condition 4: Burn of limbs sequela. Condition 5: Burn of Lower Limb sequela. Condition 6: hypertrophic scar.; Scar conditions and fibrosis of skin; Burn of unspecified degree of head, face, and neck, unspecified site, sequela; Burn of unspecified degree of trunk, unspecified site, sequela; Burn of unspecified degree of shoulder and upper limb, except wrist and hand, unspecified site, sequela; Burn of unspecified degree of unspecified site of unspecified lower limb, except ankle and foot, sequela; Hypertrophic scar; L90.5; T20.00XS; T21.00XS

• Registration Number: IRCT20221012056155N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Burn-induced scars anywhere on the trunk or limbs or face or neck
The minimal interval between burn injury and intervention(fat grafting) should not be less than one year(Mature Scars)

Exclusion Criteria

Any significant systemic disease or morbidity ( e.g. Cardiac disease, Endocrine disease, Respiratory Disease etc)
Any patient with an American Society of Anesthesiologist Physical Status Classification System score>II indicating increased anesthesia risk
Low Body Mass Index (BMI) (Less than 19kg/m²)
Known Systemic Immune Disorder (Acquired or inherited immune deficiency)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall Scar Score (Observer). Timepoint: Before intervention and three months after intervention. Method of measurement: Patient and Observer Scar Assessment Scale (POSAS) Questionnaire.;Overall Scar Score (Patient). Timepoint: Before intervention and three months after intervention. Method of measurement: Patient and Observer Scar Assessment Scale (POSAS) Questionnaire.